RKDA vs. ORIS, SANW, LOCL, SEED, NCRA, CEAD, EDBL, IVP, SISI, and AAGR
Should you be buying Arcadia Biosciences stock or one of its competitors? The main competitors of Arcadia Biosciences include Oriental Rise Holdings Limited Ordinary Shares (ORIS), S&W Seed (SANW), Local Bounti (LOCL), Origin Agritech (SEED), Nocera (NCRA), CEA Industries (CEAD), Edible Garden (EDBL), Inspire Veterinary Partners (IVP), Shineco (SISI), and African Agriculture (AAGR). These companies are all part of the "agriculture" industry.
Arcadia Biosciences vs.
Oriental Rise Holdings Limited Ordinary Shares (NASDAQ:ORIS) and Arcadia Biosciences (NASDAQ:RKDA) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their community ranking, risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.
Arcadia Biosciences received 286 more outperform votes than Oriental Rise Holdings Limited Ordinary Shares when rated by MarketBeat users.
17.7% of Arcadia Biosciences shares are owned by institutional investors. 1.8% of Arcadia Biosciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
In the previous week, Arcadia Biosciences had 1 more articles in the media than Oriental Rise Holdings Limited Ordinary Shares. MarketBeat recorded 1 mentions for Arcadia Biosciences and 0 mentions for Oriental Rise Holdings Limited Ordinary Shares. Oriental Rise Holdings Limited Ordinary Shares' average media sentiment score of 0.00 equaled Arcadia Biosciences'average media sentiment score.
Arcadia Biosciences has a consensus price target of $6.00, indicating a potential upside of 50.75%. Given Arcadia Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Arcadia Biosciences is more favorable than Oriental Rise Holdings Limited Ordinary Shares.
Oriental Rise Holdings Limited Ordinary Shares has higher revenue and earnings than Arcadia Biosciences.
Oriental Rise Holdings Limited Ordinary Shares has a net margin of 0.00% compared to Arcadia Biosciences' net margin of -110.61%. Oriental Rise Holdings Limited Ordinary Shares' return on equity of 0.00% beat Arcadia Biosciences' return on equity.
Summary
Arcadia Biosciences beats Oriental Rise Holdings Limited Ordinary Shares on 9 of the 14 factors compared between the two stocks.
Get Arcadia Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for RKDA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Arcadia Biosciences Competitors List
Related Companies and Tools
This page (NASDAQ:RKDA) was last updated on 2/22/2025 by MarketBeat.com Staff
